HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The use of monopril in elderly patients with arterial hypertension and coronary heart disease].

Abstract
We examined 20 patients (mean age 69.4 yr) with stage II AH and CHD. 13 ones suffered CHD with stable FC II and III angina, two others had myocardial infarction. The patients were given monopril, 10 mg BID (08.00 & 20.00). Those with CHD were additionally treated with cardiket (20 mg BID) or monocinque (20 mg BID). If appropriate, hypothiazide or triampur compositum (25 mg each) was given in the morning. Usual clinical examination was supplemented by dynamic studies and evaluation of clinical symptoms on day 21 after therapy including systolic and diastolic AP, pulse and mean dynamic AD, double product, heart rate, ECG, echoCG, AP and ACG monitoring. The above treatment produced marked antihypertensive and antianginal effects in the absence of adverse events.
AuthorsO A Lednev, R M Zaslavskaia, N D Buniatian, S V Sergeev
JournalKlinicheskaia meditsina (Klin Med (Mosk)) Vol. 87 Issue 12 Pg. 48-9 ( 2009) ISSN: 0023-2149 [Print] Russia (Federation)
PMID20135887 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Fosinopril
Topics
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors (administration & dosage)
  • Blood Pressure (drug effects)
  • Coronary Disease (complications, drug therapy, physiopathology)
  • Dose-Response Relationship, Drug
  • Electrocardiography (drug effects)
  • Female
  • Follow-Up Studies
  • Fosinopril (administration & dosage)
  • Humans
  • Hypertension (complications, drug therapy, physiopathology)
  • Male
  • Surveys and Questionnaires
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: